BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/1/2022 4:13:08 AM | Browse: 80 | Download: 137
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 70902
Country/Territory China
Category Gastroenterology and Hepatology
Manuscript Type Retrospective Study
Article Title Efficacy and safety of computed tomography-guided microwave ablation with fine needle-assisted puncture positioning technique for hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Ming-Zhi Hao, Yu-Bin Hu, Qi-Zhong Chen, Zhang-Xian Chen and Hai-Lan Lin
Funding Agency and Grant Number
Funding Agency Grant Number
Fujian Key Laboratory of Translational Cancer Medicine and Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy, China 2020Y2012
Corresponding Author Ming-Zhi Hao, MM, Professor, Department of Tumor Interventional Radiology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou 350014, Fujian Province, China. haomz@fjzlhospital.com
Key Words Hepatocellular carcinoma; Fine needle puncture; Microwave ablation; Recurrence-free survival; Local tumor progression
Core Tip This was a retrospective study that compared the fine needle-assisted puncture positioning (FNP) technique and conventional puncture (CP) technique for the safety and efficacy of computed tomography (CT)-guided microwave ablation (MWA) in treating hepatocellular carcinoma (HCC). In total, 124 patients were divided into two groups by the puncture technique. Seventy patients received CT-guided MWA under the FNP technique (FNP group), and 54 patients received MWA under the CP technique (CP group). The FNP technique used in CT-guided MWA may improve outcomes in terms of local tumor progression, recurrence-free survival, and procedure-related complications for HCC.
Citation Hao MZ, Hu YB, Chen QZ, Chen ZX, Lin HL. Efficacy and safety of computed tomography-guided microwave ablation with fine needle-assisted puncture positioning technique for hepatocellular carcinoma. World J Gastrointest Oncol 2022; 14(9): 1727-1738
2022-03-14 14:08
Peer-Review Started
2022-03-14 14:10
To Make the First Decision
Return for Revision
2022-04-11 23:43
2022-04-18 06:35
Second Decision
2022-07-29 02:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-08-01 04:13
Articles in Press
2022-08-01 04:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-07-12 15:26
Typeset the Manuscript
2022-08-26 01:34
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Jia-Ping Yan
Reviewer Code 05088185, 05531699, 02579144, and 02579144
Editorial Director
Journal Chief Editor
Company Chief Editor Li Ma
Language Editor Donna Fox
Production Editor Ying-Yi Yuan
Responsible Production Editor Ying-Yi Yuan
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma